Invesco Pharmaceuticals ETF Newsroom

Pharma Companies Welcome New Year With 583 Drug Price Hikes so Far

Seeking Alpha04:36

Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference

Benzinga03:12

Johnson & Johnson Pauses US Varipulse Procedures Amid Safety Review, Investigates Brain-Related Events

Benzinga01:46

Drugs Not Selected for Medicare Price Negotiation Nearly Doubled - Report

Seeking Alpha00:35

Novo, Eli Lilly to Dominate Global Pharma Sales in 2025: Report

Seeking AlphaJan 9 21:56

Breaking Down Liquidia: 4 Analysts Share Their Views

BenzingaJan 9 21:00

Liquidia Analyst Ratings

BenzingaJan 9 20:10 · Ratings

'Medicare Can Now Cover Eli Lilly's Zepbound For Sleep Apnea, CMS Says' - CNBC

BenzingaJan 9 04:32

Alger Launches Russell Innovation ETF To Capitalize On Emerging Innovators

BenzingaJan 9 03:32

Assessing AbbVie: Insights From 17 Financial Analysts

BenzingaJan 9 03:00

Johnson & Johnson Falls After Pausing Varipulse Cases

Seeking AlphaJan 9 02:31

Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies

BenzingaJan 9 01:54

8 Health Care Stocks Whale Activity In Today's Session

BenzingaJan 9 01:35

Oak Tree Capital's Marks: New things are prone to bubbles, currently private equity buying S&P 500, with a 10-year yield of only ±2%.

Max recently released a memorandum titled "Revisiting the Bubble," stating that investors are currently betting on the leading high-tech companies to maintain their dominance. However, he believes that it is not easy to stay ahead, as new technologies and competitors can surpass existing market leaders at any time. When people assume that "things can only get better" and Buy based on that, the impact of negative news can be particularly severe. He specifically pointed out the frenzy over AI and how this positive sentiment may spread to other Technology sectors.

wallstreetcnJan 9 01:08

Merck Rival Summit Draws New Buy From Truist on Deal Prospects

Seeking AlphaJan 9 00:02

Merck Downgraded by Truist to Hold Over Growth Concerns

Seeking AlphaJan 8 23:19

Pfizer Analyst Ratings

BenzingaJan 8 22:58 · Ratings

Pfizer And GSK's RSV Vaccines Safety Labels Updated, FDA Adds Warning For Rare Neurological Disorder

BenzingaJan 8 22:01

Asher Bio Announces Clinical Trial Collaboration And Supply Agreement With Amgen On Etakafusp Alfa In Combination With Bispecific T-cell Engager In Patients With Small Cell Lung Cancer

BenzingaJan 8 21:19

Merck Gets Expanded Approval From China for Its HPV Vaccine in Males

Seeking AlphaJan 8 20:55